Figure 1.
Primary Structure: Comparison of ABP 215, Bevacizumab (US), and Bevacizumab (EU) Intact Molecular Mass Profile (a), reduced peptide map (b), and glycan map (c).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.